ScreenerHero
SNTSynektik Spólka AkcyjnaPartial data
GPW · PL · Healthcare · Medical Devices · synektik.com.pl
357.00PLN-2.51%Mkt Cap: 791.03M $P/E: 17.51

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler SE
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
SN
Smith & Nephew plc
$9.73BUSDP/E 19.8
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
DEMANT
Demant A/S
$8.82BUSDP/E 25.0

Key Statistics

Company
Market Cap791.03M $
Enterprise Value—
Revenue (TTM)13.76M $
Gross Profit61.68M $
Net Income (TTM)26.07M $
Revenue/Share1.613 USD
Last Price357.00 PLN
Fiscal Year EndJun 2018
MR QuarterJun 2018
Employees—
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLSNKTK00019
Valuation
P/E (Trailing)17.51
P/E (Forward)29.78
PEG—
EV/EBITDA—
EV/Revenue—
P/S55.65
P/B42.72
EPS (TTM)20.90
EPS (Forward)11.90
52W Range
180.2085% of range388.00
52W High388.00 PLN
52W Low180.20 PLN
Profitability
Gross Margin35.73%
Oper. Margin19.72%
EBITDA Margin10.60%
Profit Margin15.10%
ROE46.04%
ROA21.04%
Growth
Revenue Growth658.80%
Earnings Growth2387.70%
Cash Flow & Leverage
Operating CF19.83M $
CapEx (TTM)4.42M $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.18
Current Ratio1.07
Quick Ratio0.80
Book Value/Sh8.295 PLN
Cash/Share—
Dividends
Fwd Div Rate10.75 PLN
Trail. Div Rate0.0000 PLN
Div. Yield3.01%
5Y Avg Yield2.12%
Payout Ratio51.44%
Ex-Div DateJan 28, 2026
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)373.00 PLN
Upside (mean)+4.5%
Target Range323.00 PLN – 419.00 PLN
PLN323.00+4.5% to meanPLN419.00
# Analysts5
Ownership
Shares Out.8.53M
Float3.96M
Insiders40.14%
Institutions18.08%
Technical
SMA 50347.82 (+2.6%)
SMA 200299.34 (+19.3%)
Beta0.03
S&P 52W Chg19.97%
Avg Vol (30d)47.48K
Avg Vol (10d)52.63K
Technical Indicators
RSI (14)74.7
MACD21.5173
MACD Signal14.4753
MACD Hist.+7.0420
BB Upper381.78 PLN
BB Middle315.63 PLN
BB Lower249.48 PLN
BB Width41.92%
ATR (14)13.95 PLN
Vol Ratio (20d)1.25x